Rescue abciximab for complicated percutaneous transluminal coronary angioplasty

被引：12

作者：

Garbarz, E

Farah, B

Vuillemenot, A

André, F

Angioï, M

Machecourt, J

Bassand, JP

Wolf, JE

Danchin, N

Prendergast, B

Iung, B

Vahanian, A

机构：

[1] Tenon Hosp, Dept Cardiol, F-75020 Paris, France

[2] Dept Cardiol, Besancon, France

[3] Dept Cardiol, Dijon, France

[4] Dept Cardiol, Nancy, France

[5] Dept Cardiol, Grenoble, France

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 1998年 / 82卷 / 06期

关键词：

D O I：

10.1016/S0002-9149(98)00459-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We studied the in-hospital outcome of 138 consecutive patients who received abciximab as a "rescue" intervention for complicated coronary angioplasty in a high-risk clinical setting. "Rescue" treatment with abciximab was associated with clinical and angiographic success rates of 83% and 84%, respectively, whereas the risk of bleeding was higher in patients of low body weight.

引用

页码：800 / +

页数：5

共 17 条

[1]

Betriu A, 1997, NEW ENGL J MED, V336, P1621

[2]

BRENER JJ, 1996, CIRCULATION S1, V94, P375

[3] USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY [J].

CALIFF, RM ;

SHADOFF, N ;

VALETT, N ;

BATES, E ;

GALEANA, A ;

KNOPF, W ;

SHAFTEL, J ;

BENDER, MJ ;

AVERSANO, T ;

RAQUENO, J ;

GURBEL, P ;

COWFER, J ;

COHEN, M ;

CROSS, P ;

BITTL, J ;

EDDINGS, K ;

TAYLOR, M ;

DEROSA, K ;

HATTEL, L ;

COOPER, L ;

ESHELMAN, B ;

FINTEL, D ;

NIEMYSKI, P ;

KLEIN, L ;

KENNEDY, H ;

THORNTON, T ;

KEREIAKES, D ;

MARTIN, L ;

ANDERSON, L ;

HIGBY, N ;

ELLIS, S ;

BREZINA, K ;

GEORGE, B ;

CHAPEKIS, A ;

SMITH, D ;

ANWAR, A ;

GERBER, TL ;

PRITCHARD, GL ;

MYLER, R ;

SHAW, R ;

MURPHY, M ;

WARD, K ;

MADIGAN, NP ;

BLANKENSHIP, J ;

HALBERT, M ;

FLANAGAN, C ;

TANNENBAUM, M ;

POLICH, M ;

STEVENSON, C ;

TCHENG, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :956-961

[4] BLOCKADE OF PLATELET GPIIB/IIIA RECEPTORS AS AN ANTITHROMBOTIC STRATEGY [J].

COLLER, BS .

CIRCULATION, 1995, 92 (09) :2373-2380

[5] PLATELET ACTIVATION DURING CORONARY ANGIOPLASTY IN HUMANS [J].

GASPERETTI, CM ;

GONIAS, SL ;

GIMPLE, LW ;

POWERS, ER .

CIRCULATION, 1993, 88 (06) :2728-2734

[6]

Gold HK, 1997, CIRCULATION, V95, P1755

[7]

Henry P, 1998, CATHETER CARDIO DIAG, V43, P105, DOI 10.1002/(SICI)1097-0304(199801)43:1<105::AID-CCD30>3.0.CO

[8]

2-M

[9] MEDICAL PROGRESS - PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY [J].

LANDAU, C ;

LANGE, RA ;

HILLIS, LD .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :981-993

[10] Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction [J].

Lefkovits, J ;

Ivanhoe, RJ ;

Califf, RM ;

Bergelson, BA ;

Anderson, KM ;

Stoner, GL ;

Weisman, HF ;

Topol, EJ .

AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (12) :1045-1051

← 1 2 →